Template:Anticonvulsants: Difference between revisions
Content deleted Content added
Matthew Proctor (talk | contribs) mNo edit summary |
AlyInWikiWonderland (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
| title = [[Anticonvulsant]]s ([[ATC_code_N03|N03]]) |
| title = [[Anticonvulsant]]s ([[ATC_code_N03|N03]]) |
||
| state = {{{state|autocollapse}}} |
| state = {{{state|autocollapse}}} |
||
|listclass = hlist |
| listclass = hlist |
||
| groupstyle = background: LemonChiffon |
| groupstyle = background-color: LemonChiffon |
||
| group1 = [[ |
| group1 = [[gamma-Aminobutyric acid|GABA]] enhancers |
||
| list1 = {{Navbox subgroup |
| list1 = {{Navbox subgroup |
||
| groupstyle = background-color: LemonChiffon |
| groupstyle = background-color: LemonChiffon |
||
| group1 = [[ |
| group1 = [[GABAA receptor|GABA<sub>A</sub>R]] [[positive allosteric modulator|PAM]]s |
||
| list1 = |
| list1 = |
||
* [[Barbexaclone]] |
* '''[[Barbiturate]]s:''' [[Barbexaclone]] |
||
* [[Metharbital]] |
* [[Metharbital]] |
||
* [[Methylphenobarbital]] |
* [[Methylphenobarbital]] |
||
* [[Pentobarbital]] |
* [[Pentobarbital]] |
||
* [[Phenobarbital]]<sup>#</sup> |
* [[Phenobarbital]]<sup>#</sup> |
||
* [[Primidone]]; '''[[Carbamate]]s''': [[Felbamate]]; '''[[Benzodiazepine]]s''': [[Clobazam]] |
|||
* [[Primidone]] |
|||
| group2 = [[Benzodiazepine]]s |
|||
| list2 = |
|||
* [[Clobazam]] |
|||
* [[Clonazepam]] |
* [[Clonazepam]] |
||
* [[Clorazepate]] |
* [[Clorazepate]] |
||
* [[Diazepam]]<sup>#</sup> |
* [[Diazepam]]<sup>#</sup> |
||
* [[Flutoprazepam]] |
|||
* [[Lorazepam]]<sup>#</sup> |
* [[Lorazepam]]<sup>#</sup> |
||
* [[Midazolam]] |
* [[Midazolam]] |
||
| Line 32: | Line 27: | ||
* [[Temazepam]] |
* [[Temazepam]] |
||
| group2 = [[GABA transaminase inhibitor|GABA-T inhibitors]] |
|||
}} |
|||
| list2 = |
|||
* '''[[Fatty acid]]s:''' [[Valproic acid]]<sup>#</sup> ([[sodium valproate]], [[valproate semisodium]]) |
|||
* [[Valpromide]] |
|||
* [[Valproate pivoxil]]; '''Others:''' [[Vigabatrin]] |
|||
| group3 = Others |
|||
| group2 = Other GABA agents |
|||
| list3 = |
|||
| list2 = {{Navbox subgroup |
|||
* '''[[GABA agonist|GABAR agonist]]s''': [[Progabide]]; '''[[GABA reuptake inhibitor|GAT-1 inhibitor]]s:''' [[Tiagabine]]; '''Others:''' [[Bromide]] ([[potassium bromide]], [[sodium bromide]]) |
|||
| groupstyle = background-color: LemonChiffon |
|||
* [[Paraldehyde]] |
|||
| group1 = [[Aromaticity|Aromatic]] [[allylic]] [[alcohol]]s |
|||
| list1 = |
|||
* [[Stiripentol]] |
* [[Stiripentol]] |
||
}} |
}} |
||
| group2 = [[Ion channel]] modulators |
|||
| group3 = [[Carbonic anhydrase inhibitor]] |
|||
| |
| list2 = {{Navbox subgroup |
||
| groupstyle = background-color: LemonChiffon |
| groupstyle = background-color: LemonChiffon |
||
| group1 = [[ |
| group1 = [[Sodium channel blocker|Sodium blocker]]s |
||
| list1 = |
| list1 = |
||
* '''[[Hydantoin]]s:''' [[Ethotoin]] |
|||
* [[Acetazolamide]] |
|||
* [[Ethoxzolamide]] |
|||
* [[Sultiame]] |
|||
* [[Zonisamide]] |
|||
}} |
|||
| group4 = Channel blockers |
|||
| list4 = {{Navbox subgroup |
|||
| groupstyle = background-color: LemonChiffon |
|||
| group1 = Primarily [[sodium channel blocker|sodium]] |
|||
| list1 = {{Navbox subgroup |
|||
| groupstyle = background-color: LemonChiffon |
|||
| group1 = [[Hydantoin]]s |
|||
| list1 = |
|||
* [[Ethotoin]] |
|||
* [[Fosphenytoin]] |
* [[Fosphenytoin]] |
||
* [[Mephenytoin]] |
* [[Mephenytoin]] |
||
* [[Phenytoin]]<sup>#</sup> |
* [[Phenytoin]]<sup>#</sup>; '''[[Urea]]s:''' [[Phenacemide]] |
||
* [[Pheneturide]]; '''[[Fatty acid]]s:''' [[Valproic acid]]<sup>#</sup> ([[sodium valproate]], [[valproate semisodium]]) |
|||
* [[Valpromide]] |
|||
| group6 = [[Carboxamide]]s |
|||
* [[Valproate pivoxil]]; '''[[Carboxamide]]s:''' [[Carbamazepine]]<sup>#</sup> |
|||
| list6 = |
|||
* [[Carbamazepine]]<sup>#</sup> |
|||
* [[Eslicarbazepine acetate]] |
* [[Eslicarbazepine acetate]] |
||
* [[Oxcarbazepine]] |
* [[Oxcarbazepine]]; '''Others:''' [[Lacosamide]] |
||
* [[ |
* [[Lamotrigine]] |
||
* [[Rufinamide]] |
* [[Rufinamide]] |
||
* [[Topiramate]] |
|||
* [[Zonisamide]] |
|||
| group2 = [[Calcium channel blocker|Calcium blocker]]s |
|||
}} |
|||
| list2 = |
|||
* '''[[Oxazolidinedione]]s:''' [[Ethadione]] |
|||
| group2 = Primarily [[calcium channel blocker|calcium]] |
|||
* [[Paramethadione]] |
|||
| list2 = {{Navbox subgroup |
|||
* [[Trimethadione]]; '''[[Succinimide]]s''': [[Ethosuximide]]<sup>#</sup> |
|||
| groupstyle = background-color: LemonChiffon |
|||
| group4 = [[Succinimide]]s |
|||
| list4 = |
|||
* [[Ethosuximide]]<sup>#</sup> |
|||
* [[Mesuximide]] |
* [[Mesuximide]] |
||
* [[Phensuximide]] |
* [[Phensuximide]]; '''[[Gabapentinoid]]s:''' [[Gabapentin]] |
||
* [[Pregabalin]]; '''Others:''' [[Lamotrigine]] |
|||
* [[Topiramate]] |
|||
* [[Zonisamide]] |
|||
| group3 = [[Potassium channel opener|Potassium opener]]s |
|||
}} |
|||
| list3 = |
|||
* [[Retigabine]] |
|||
|group3 = [[AMPA receptor]] |
|||
|list3 = |
|||
* [[Perampanel]] |
|||
|group4 = Unknown/ungrouped |
|||
|list4 = |
|||
* ''[[Phenyltriazine]]'' ([[Lamotrigine]]), ''[[Oxazolidinedione]]s'' ([[Ethadione]] |
|||
* [[Paramethadione]] |
|||
* [[Trimethadione]]), ''[[Urea]]s'' ([[Phenacemide]] |
|||
* [[Pheneturide]]), ''[[Monosaccharide]]'' ([[Topiramate]]) |
|||
}} |
}} |
||
| group3 = Others |
|||
| group5 = Channel openers |
|||
| |
| list3 = {{Navbox subgroup |
||
| groupstyle = background-color: LemonChiffon |
| groupstyle = background-color: LemonChiffon |
||
| group1 = [[ |
| group1 = [[Carbonic anhydrase inhibitor|CA inhibitor]]s |
||
| list1 = |
| list1 = |
||
* '''[[Sulfonamide (medicine)#Anticonvulsant|Sulfonamide]]s:''' [[Acetazolamide]] |
|||
* [[Retigabine]] |
|||
* [[Ethoxzolamide]] |
|||
* [[Sultiame]] |
|||
}} |
|||
| group6 = Indirect GABA agents |
|||
| list6 = {{Navbox subgroup |
|||
| groupstyle = background-color: LemonChiffon |
|||
| group3 = [[Carboxylic acid]]s/<br />[[Fatty acid|Fatty acid derivatives]] |
|||
| list3 = |
|||
* [[GABA transaminase inhibitor]]: [[Valproic acid]]<sup>#</sup> ([[Sodium valproate]] & [[Valproate semisodium]]) |
|||
* [[Valpromide]] |
|||
* [[Valnoctamide]] |
|||
* [[Valproate pivoxil]] |
|||
[[GABA reuptake inhibitor]]: [[Tiagabine]] |
|||
| group8 = [[Gamma-Aminobutyric acid|GABA analog]]s |
|||
| list8 = |
|||
* [[Gabapentin]] |
|||
* [[Pregabalin]] |
|||
* [[Progabide]] |
|||
* [[Tolgabide]] |
|||
* [[Vigabatrin]] |
|||
}} |
|||
| group7 = Unknown/multiple/<br />unsorted |
|||
| list7 = {{Navbox subgroup |
|||
| groupstyle = background-color: LemonChiffon |
|||
| group6 = [[Carbamate]]s/[[sulfamate]]s |
|||
| list6 = |
|||
* [[Carisbamate]]<sup>†</sup> |
|||
* [[Emylcamate]] |
|||
* [[Felbamate]] |
|||
* [[JNJ-26990990]]<sup>§</sup> |
|||
* [[Meprobamate]] |
|||
* [[Topiramate]] |
* [[Topiramate]] |
||
* [[Zonisamide]] |
|||
| group2 = Others |
|||
| group7 = [[Pyrrolidine]]s |
|||
| |
| list2 = |
||
* [[ |
* [[Beclamide]] |
||
* [[Levetiracetam]] |
* [[Levetiracetam]] |
||
* [[Nefiracetam]] |
|||
* [[Seletracetam]] |
|||
| group9 = [[Propanoate|Propionate]]s |
|||
| list9 = |
|||
* [[Beclamide]] |
|||
* [[Lacosamide]] |
|||
| group10 = [[Aldehyde]]s |
|||
| list10 = |
|||
* [[Paraldehyde]] |
|||
| group11 = [[Bromide]]s |
|||
| list11 = |
|||
* [[Potassium bromide]] |
|||
* [[Sodium bromide]] |
|||
}} |
}} |
||
| belowstyle = background: transparent; padding: 0px; |
| belowstyle = background: transparent; padding: 0px; |
||
| below = {{PharmNavFootnote}} |
| below = {{PharmNavFootnote}}{{Psychology navs}} |
||
}}<noinclude> |
}}<noinclude> |
||
{{collapsible option}} |
{{collapsible option}} |
||
[[Category: |
[[Category:Anxiolytics]] |
||
[[Category:Drug_templates by ATC]] |
[[Category:Drug_templates by ATC]] |
||
<!--fr:Modèle:Antiépileptique--> |
|||
</noinclude> |
</noinclude> |
||
Revision as of 05:12, 21 July 2014
This template's initial visibility currently defaults to autocollapse, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible.
To change this template's initial visibility, the |state= parameter may be used:
{{Anticonvulsants|state=collapsed}}will show the template collapsed, i.e. hidden apart from its title bar.{{Anticonvulsants|state=expanded}}will show the template expanded, i.e. fully visible.